Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium.
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2016
At a glance
- Drugs Vinflunine (Primary) ; Carboplatin; Gemcitabine
- Indications Urogenital cancer
- Focus Therapeutic Use
- Acronyms JASINT1
- Sponsors Pierre Fabre
- 16 Dec 2015 Results published in the Annals of Oncology
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
- 01 Oct 2013 Preliminary results in the first 43 recruited patients presented at the 2013 European Cancer Congress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History